The majority of the matter in our Universe isn’t made of any of the particles in the Standard Model. Could the axion save the day?
Discussions about asteroid 2024 GJ2 near miss with Earth on 11 Apr 24, and asteroids Apophis, Bennu, potential impacts and more!
GoldBacks from Green Greg’s affiliate link:
https://www.defythegrid.com/goldbacks…
Use coupon code GreenGregs for 1% off.
Outstanding Antioxidant For Your Health: https://shopc60.com/
Use discount code: GreenGregs10 for 10% off.
Inspire your kids to love science!
From U tubingen and cambridge U
Wu’s Method can Boost Symbolic AI to Rival Silver Medalists and AlphaGeometry to Outperform Gold Medalists at IMO Geometry https://arxiv.org/abs/2404.
- Wu’s…
Our AI system surpasses the state-of-the-art approach for geometry problems, advancing AI reasoning in mathematics.
🧬🔬💊
Comprehensive review reveals the significant impact of tumor-resident bacteria on metastatic cancer, showing how microbiome genomes influence tumor biology, immune system response, and treatment effectiveness. It lays the groundwork for utilizing bacteria-focused therapies to complement traditional cancer treatments.
Dive into this newest article featuring an unique case study of Pituitary Apoplexy in Macroadenoma following minor surgery. Explore more by tapping the link 👉
Pituitary apoplexy is a rare and severe complication of pituitary adenoma that may present with new-onset headache, ocular palsy, visual disturbances, life-threatening electrolyte imbalance, and endocrinological disturbances due to pituitary hemorrhage and/or infarction.
We report the case of a 58-year-old previously healthy patient who developed isolated mild oculomotor nerve palsy of the left eye following osteosynthesis of a traumatic right distal radius fracture. Initial cerebral magnetic resonance imaging showed a pituitary macroadenoma without characteristic signs of pituitary infarction or hemorrhage. The patient presented to the neurology department on the fifth postoperative day with malaise and fatigue due to pituitary insufficiency, deteriorated rapidly and required intensive care monitoring.
Google announces Leave No Context Behind.
Efficient Infinite Context Transformers with Infini-attention.
This work introduces an efficient method to scale Transformer-based Large Language Models (LLMs) to infinitely long inputs with bounded memory and…
Join the discussion on this paper page.
The proton engine Einstein predicted, created for the first time: challenges the laws of the universe and makes cars sustainable
Posted in nuclear energy, physics, space, sustainability | 1 Comment on The proton engine Einstein predicted, created for the first time: challenges the laws of the universe and makes cars sustainable
Do you know what they’ve discovered? This is the proton engine that Einstein predicted decades ago and that, for the first time, they’ve managed to materialize. The best part? It challenges even the laws of physics and the universe, and it’s going to decarbonize transportation.
Nuclear fusion has long been a sought-after but elusive goal for science. It involves joining atomic nuclei to release energy, the same process that occurs in the Sun and other stars. In fact, it’s a process similar to what we saw two weeks ago with the plasma engine.
Unlike nuclear fission used in current nuclear power plants—which, remember, we are highly critical of due to its lack of being an eco-friendly or renewable option—fusion offers the promise of a virtually inexhaustible and clean energy source.
An international research team from Innsbruck and Geneva has, for the first time, probed the dimensional crossover for ultracold quantum matter. In the regime between one and two dimensions, the quantum particles perceive their world as being 1D or 2D depending on the length scale on which they are probed: For short distances, their world is 1D, but it is 2D for long distances.
‘‘The reason why no such glory has ever been observed outside our solar system is that this phenomenon requires very specific conditions, said Dr. Olivier Demangeon.
A recent study published in Astronomy & Astrophysics examines rainbow-like light patterns known as “glories” between the dayside and nightside of the exoplanet, WASP-76b, which occurs from the interactions between the parent star’s light and perfectly uniform droplets within a planet’s atmosphere. This study holds the potential to help astronomers better understand exoplanet characteristics, as this marks the first time these “glory” patterns have been observed outside of our solar system.
Artist’s rendition of a “glory” on WASP-76b. (Credit: © ESA, work performed by ATG under contract for ESA. CC BY-SA 3.0 IGO)
While WASP-76b was discovered in 2013, astronomers have been puzzled by its peculiar behavior along the exoplanet’s terminator, which is the separation point between the dayside and nightside. For example, astronomers have noted higher amounts of light along the east part of WASP-76b compared to the west part of the exoplanet.
Is Chief Impact Officer for StartUp Health’s Alzheimer’s Moonshot (https://www.startuphealth.com/alzheimers), a new global initiative created to develop a collaborative innovation community alongside leading companies, research teams, and stakeholders, with a mission to accelerate progress in prevention, diagnosis, and management of Alzheimer’s disease and related dementias. With support from the Alzheimer’s Drug Discovery Foundation (ADDF) and Gates Ventures, StartUp Health is looking to break down silos and foster meaningful collaboration between mission-aligned founders, funders, and partners.
Dr. Ferrell also serves as Strategic Advisor, Davos Alzheimer’s Collaborative (https://www.davosalzheimerscollaborat…) which is building a global clinical trial network and technology platform that will link trial sites around the world.
Prior to these roles, Dr. Ferrell served almost three decades at multiple roles at Eli Lilly including as Global Head External Engagement, Alzheimer’s and Neurodegeneration, Chief Commercial Services Officer, and Vice President, Global Alzheimer’s Disease Platform Team Leader in Lilly BioMedicines, where her team were responsible for the late-stage development, global registration and launch of 4 late-stage assets including Solanezumab, Amyvid and AZD3293.
Dr. Ferrell received a DrPH, Public Health from Indiana University Richard M. Fairbanks School of Public Health, an MBA in General Management and a certificate in Public Management from the Stanford University Graduate School of Business, and a Bachelor of Arts degree in economics and management from DePauw University.